BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maneeton N, Maneeton B, Putthisri S, Suttajit S, Likhitsathian S, Srisurapanont M. Aripiprazole in acute treatment of children and adolescents with autism spectrum disorder: a systematic review and meta-analysis. Neuropsychiatr Dis Treat 2018;14:3063-72. [PMID: 30519027 DOI: 10.2147/NDT.S174622] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Mohr P, Masopust J, Kopeček M. Dopamine Receptor Partial Agonists: Do They Differ in Their Clinical Efficacy? Front Psychiatry 2022;12:781946. [DOI: 10.3389/fpsyt.2021.781946] [Reference Citation Analysis]
2 Solmi M, Fornaro M, Ostinelli EG, Zangani C, Croatto G, Monaco F, Krinitski D, Fusar-Poli P, Correll CU. Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects. World Psychiatry 2020;19:214-32. [PMID: 32394557 DOI: 10.1002/wps.20765] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 15.5] [Reference Citation Analysis]
3 Scibelli J, Scibelli F, Luiselli JK, Hrdina J, Anglin K, Orchanian S. Clinical Safety and Treatment of Severe Aggression: Behavioral-Pharmacological Intervention Evaluation in a Young Adult With Autism Spectrum Disorder. Clinical Case Studies. [DOI: 10.1177/15346501221081254] [Reference Citation Analysis]
4 Correll CU, Cortese S, Croatto G, Monaco F, Krinitski D, Arrondo G, Ostinelli EG, Zangani C, Fornaro M, Estradé A, Fusar-Poli P, Carvalho AF, Solmi M. Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review. World Psychiatry 2021;20:244-75. [PMID: 34002501 DOI: 10.1002/wps.20881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
5 Sugimoto Y, Yamamura K, Takayama T, Fukuta Y, Aoki K, Mikami K, Tomoda A. Aripiprazole in the real-world treatment for irritability associated with autism spectrum disorder in children and adolescents in Japan: 52-week post-marketing surveillance. BMC Psychiatry 2021;21:204. [PMID: 33888067 DOI: 10.1186/s12888-021-03201-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Stewart Campbell A, Needham BD, Meyer CR, Tan J, Conrad M, Preston GM, Bolognani F, Rao SG, Heussler H, Griffith R, Guastella AJ, Janes AC, Frederick B, Donabedian DH, Mazmanian SK. Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trial. Nat Med. [DOI: 10.1038/s41591-022-01683-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Carmassi C, Bertelloni CA, Salarpi G, Diadema E, Avella MT, Dell'Oste V, Dell'Osso L. Is There a Major Role for Undetected Autism Spectrum Disorder with Childhood Trauma in a Patient with a Diagnosis of Bipolar Disorder, Self-Injuring, and Multiple Comorbidities? Case Rep Psychiatry 2019;2019:4703795. [PMID: 31249714 DOI: 10.1155/2019/4703795] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
8 Mandic-maravic V, Grujicic R, Milutinovic L, Munjiza-jovanovic A, Pejovic-milovancevic M. Dopamine in Autism Spectrum Disorders—Focus on D2/D3 Partial Agonists and Their Possible Use in Treatment. Front Psychiatry 2022;12:787097. [DOI: 10.3389/fpsyt.2021.787097] [Reference Citation Analysis]
9 D'Alò GL, De Crescenzo F, Amato L, Cruciani F, Davoli M, Fulceri F, Minozzi S, Mitrova Z, Morgano GP, Nardocci F, Saulle R, Schünemann HJ, Scattoni ML; ISACA Guideline Working Group. Impact of antipsychotics in children and adolescents with autism spectrum disorder: a systematic review and meta-analysis. Health Qual Life Outcomes 2021;19:33. [PMID: 33494757 DOI: 10.1186/s12955-021-01669-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Joon P, Kumar A, Parle M. What is autism? Pharmacol Rep 2021;73:1255-64. [PMID: 33694100 DOI: 10.1007/s43440-021-00244-0] [Reference Citation Analysis]
11 Vanderwall R, Rotta K, Ehrhardt K, Poling A. Using Aripiprazole to Benefit People with Autism Spectrum Disorder: a Critical Appraisal. Adv Neurodev Disord 2021;5:1-10. [DOI: 10.1007/s41252-020-00190-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]